Cross Atlantic Partners Overview
- Investor Type
-
PE/Buyout
- Status
-
Inactive
- Investments
-
27
- Exits
-
20

Cross Atlantic Partners General Information
Description
Cross Atlantic Ventures was an investment firm which invested in private and public companies through off-market negotiated transactions. It specialized exclusively in the healthcare and life science fields, drug discovery, devices and service sectors. It specialized in early venture, late venture, growth capital and PIPE investments. The firm was established in 1994 and was based in New York, New York.
Contact Information
Website
www.crossatlanticpartners.com
Year Founded
1994
Investor Status
Out of Business
Primary Investor Type
PE/Buyout
Other Investor Types
Growth/Expansion
Venture Capital
Primary Office
- 445 Park Avenue
- 3rd Floor
- New York, NY 10022
- United States
Cross Atlantic Partners Investments & Acquisitions (27)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Labcyte | 19-Sep-2013 | 00000 00000 | 00.000 | Other Healthcare Technology Systems | Generating Revenue | 000000 00000 00.0 |
Sapphire Digital | 08-Nov-2011 | 00000 00000 | 0000 | Other Healthcare Services | Generating Revenue | |
IntegriChain | 12-Apr-2011 | 00000 00000 | 000 | Business/Productivity Software | Profitable | 0000 000000 |
Ore Holdings | 22-Oct-2010 | 000000000000 | 00.00 | Private Equity | Generating Revenue | |
Palyon Medical | 10-Aug-2009 | Early Stage VC | 0000 | Therapeutic Devices | Bankruptcy: Liquidation |
Cross Atlantic Partners Exits (20)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Labcyte | 30-Jan-2019 | 000000000000000000 | |
Sapphire Digital | 01-Aug-2018 | 000000000000000000 | |
Ore Holdings | 17-Aug-2017 | 000000000 00000000 | |
GQ Life Sciences | 03-Oct-2016 | 0000000000 | |
BioMedical Enterprises | 09-May-2016 | Merger/Acquisition |